Parathyroid Cancer Versus Atypical Parathyroid Neoplasm; Investigating Their Clinical Characteristics and Biological Behavior

Completed

Conditions studied: Parathyroid Carcinoma, Parathyroid Neoplasm

In brief

Objectives: 1. Identify the clinical characteristics of parathyroid (PTH) cancer and PTH atypical neoplasms 2. Investigate if PTH carcinoma and atypical neoplasm present a biological behaviour and have a different impact on the health of the patients

Key facts

Study ID

NCT03046524

Run by

M.D. Anderson Cancer Center

People needed

100

Starts

2015-10-06

Expected to finish

2017-10-16

Last updated by the study team

2018-02-07

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• All patients from MDACC diagnosed with PHPT that have a histopathological diagnosis of PTH carcinoma or atypical parathyroid neoplasm between the years 1/1/2002 and 12/31/2013

You may not qualify if…

• Pediatric patients
• Cases with incomplete records
• Patients where the follow-up will be less than six months

Where it is running

• University of Texas MD Anderson Cancer Center — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.